US Stock MarketDetailed Quotes
JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
- 0.1616
- +0.0144+9.78%
Close Apr 18 16:00 ET
0Market Cap0.00P/E (TTM)
0.1690High0.1101Low8.32KVolume0.1674Open0.1472Pre Close1.14KTurnover0.00%Turnover Ratio3.67P/E (Static)0Shares0.381852wk High0.00P/B0Float Cap0.035152wk Low--Dividend TTM0Shs Float2.2400Historical High--Div YieldTTM40.01%Amplitude0.0160Historical Low0.1370Avg Price1Lot Size
JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -13.54%-52.07M | -30.31%-16.48M | -24.25%-11.98M | -41.86%-13.27M | 27.28%-10.34M | -36.17%-45.86M | 13.29%-12.65M | -35.66%-9.64M | -61.56%-9.36M | -129.43%-14.21M |
| Net income from continuing operations | -71.06%-64.47M | -25.51%-16.58M | -47.89%-17.54M | -54.56%-16.08M | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M |
| Operating gains losses | 107.99%575K | --0 | --0 | --0 | 109.50%575K | -339.92%-7.2M | -200.00%-150K | 65.56%-155K | ---845K | -272.81%-6.05M |
| Depreciation and amortization | 13.64%1.11M | 3.66%283K | 2.99%276K | 26.15%275K | 26.85%274K | 158.62%975K | 40.72%273K | 103.03%268K | 651.72%218K | 881.82%216K |
| Other non cash items | 107.44%401K | 833.33%84K | 31.33%-228K | 40.00%-318K | 119.02%863K | 40.69%-5.39M | 100.30%9K | 94.69%-332K | -702.27%-530K | -4,826.04%-4.54M |
| Change In working capital | 886.29%5.1M | -21.52%-1.42M | 129.53%4.12M | 28.07%1.46M | 139.20%946K | -140.04%-649K | 59.44%-1.17M | -33.12%1.8M | -48.44%1.14M | -523.51%-2.41M |
| -Change in receivables | 200.00%663K | --0 | --0 | --0 | --663K | -210.50%-663K | ---663K | --0 | --0 | --0 |
| -Change in prepaid assets | 145.83%767K | 48.42%-700K | 38.87%1.4M | -61.92%353K | -7.81%-290K | 114.10%312K | 29.54%-1.36M | 162.60%1.01M | 713.16%927K | 65.73%-269K |
| -Change in payables and accrued expense | 495.59%5.2M | 223.10%469K | 205.87%2.92M | 488.83%1.05M | 136.82%761K | -133.74%-1.32M | 3.54%-381K | -37.57%954K | -93.97%179K | -918.23%-2.07M |
| -Change in other current assets | -412.28%-584K | -331.48%-932K | 0.00%34K | 723.53%280K | 0.00%34K | 67.15%-114K | 37.75%-216K | -94.92%34K | 105.08%34K | --34K |
| -Change in other current liabilities | -183.55%-945K | -117.98%-260K | -15.69%-236K | ---227K | -100.00%-222K | 456.78%1.13M | 760.27%1.45M | -300.00%-204K | --0 | -11,200.00%-111K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -13.54%-52.07M | -30.31%-16.48M | -24.25%-11.98M | -41.86%-13.27M | 27.28%-10.34M | -36.17%-45.86M | 13.29%-12.65M | -35.66%-9.64M | -61.56%-9.36M | -129.43%-14.21M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 53.65%-267K | -180.49%-230K | 0 | 95.47%-11K | 10.34%-26K | 76.28%-576K | 88.47%-82K | 52.77%-222K | 15.33%-243K | 96.98%-29K |
| Net PPE purchase and sale | 53.65%-267K | -180.49%-230K | --0 | 95.47%-11K | 10.34%-26K | 76.28%-576K | 88.47%-82K | 52.77%-222K | 15.33%-243K | 96.98%-29K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 53.65%-267K | -180.49%-230K | --0 | 95.47%-11K | 10.34%-26K | 76.28%-576K | 88.47%-82K | 52.77%-222K | 15.33%-243K | 96.98%-29K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 183,483.64%100.97M | -1,067.86%-271K | 3,500.00%36K | -2,446.15%-305K | 780,753.85%101.51M | -99.95%55K | 103.08%28K | -100.00%1K | 102.17%13K | -99.88%13K |
| Net common stock issuance | --101.48M | --0 | --0 | --0 | --101.48M | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 721.82%452K | 0.00%28K | 3,500.00%36K | 2,638.46%356K | 146.15%32K | -76.69%55K | -17.65%28K | -99.24%1K | -80.88%13K | 550.00%13K |
| Net other financing activities | ---960K | ---299K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 183,483.64%100.97M | -1,067.86%-271K | 3,500.00%36K | -2,446.15%-305K | 780,753.85%101.51M | -99.95%55K | 103.08%28K | -100.00%1K | 102.17%13K | -99.88%13K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.53%38.67M | 103.02%104.28M | 89.82%116.23M | 83.31%129.82M | -54.53%38.67M | 321.37%85.05M | -49.27%51.37M | 258.03%61.23M | 197.80%70.82M | 321.37%85.05M |
| Current changes in cash | 204.87%48.64M | -33.70%-16.98M | -21.10%-11.95M | -41.75%-13.59M | 740.59%91.15M | -171.50%-46.38M | 21.62%-12.7M | -111.72%-9.86M | -43.55%-9.59M | -495.58%-14.23M |
| End cash Position | 125.78%87.3M | 125.78%87.3M | 103.02%104.28M | 89.82%116.23M | 83.31%129.82M | -54.53%38.67M | -54.53%38.67M | -49.27%51.37M | 258.03%61.23M | 197.80%70.82M |
| Free cash flow | -12.71%-52.33M | -31.28%-16.71M | -21.45%-11.98M | -38.38%-13.28M | 27.25%-10.36M | -28.60%-46.43M | 16.78%-12.73M | -30.18%-9.87M | -57.93%-9.6M | -99.05%-14.24M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg